ERDRP-0519
CAS No. 1374006-96-8
ERDRP-0519( —— )
Catalog No. M33982 CAS No. 1374006-96-8
ERDRP-0519 is an orally bioavailable small-molecule inhibitor of the Measles virus (MeV) polymerase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 211 | Get Quote |
|
| 5MG | 330 | Get Quote |
|
| 10MG | 464 | Get Quote |
|
| 25MG | 722 | Get Quote |
|
| 50MG | 1030 | Get Quote |
|
| 100MG | 1332 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameERDRP-0519
-
NoteResearch use only, not for human use.
-
Brief DescriptionERDRP-0519 is an orally bioavailable small-molecule inhibitor of the Measles virus (MeV) polymerase.
-
DescriptionERDRP-0519, an orally bioavailable small-molecule Measles virus (MeV) polymerase inhibitor, prevents measles disease in squirrel monkeys (Saimiri sciureus). ERDRP-0519 inhibits morbilliviruses with nanomolar potency..
-
In VitroERDRP-0519 exhibits potency against a panel of Measles virus (MeV) isolates with EC50s of 0.07- 0.3 μM. ERDRP-0519 exhibits potency against MeV and related pathogens of the?Morbillivirus?genus, such as canine distemper virus (CDV).
-
In VivoA single-dose pharmacokinetic (PK) study is performed in squirrel monkeys by oral (intragastric) delivery of ERDRP-0519 (50?mg/kg) and blood sampling at seven predefined time points after dosing. Serum concentrations peak ~2?h post-administration (Cmax=3.27?μM).
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
RecptorAntiviral
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1374006-96-8
-
Formula Weight529.58
-
Molecular FormulaC23H30F3N5O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (188.83 mM; Ultrasonic )
-
SMILESCn1nc(cc1C(=O)Nc1ccc(cc1)S(=O)(=O)N1CCCC[C@H]1CCN1CCOCC1)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stefanie A Krumm, et al. An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model. Sci Transl Med.?2014 Apr 16;6(232):232ra52.?
molnova catalog
related products
-
DPPG sodium
DPPG sodium (1,2-Dipalmitoyl-sn-glycero-3-PG sodium) is a liposome that is a surfactant and inhibits cowpox virus infection.
-
Antiviral agent 38
2H-Pyrido[2',1':3,4]pyrazino[1,2-b]indazole-3-carboxylic acid, 6-(1, 1-Dimethylethyl)-6, 7-Dihydro-10 -(3-methoxypropoxy)-2-oxo-, (6R)- has antibacterial and antiviral activity and can be used to study Hepatitis B virus.
-
Pritelivir
Pritelivir (BAY 57-1293) is a potent helicase-primase inhibitor with active against HSV-1 and HSV-2 (IC50: 20 nM).
Cart
sales@molnova.com